Literature DB >> 28286878

Contrast Enhanced Ultrasound in CT-undetermined Focal Liver Lesions.

S W Sandrose1, S Karstrup2, O Gerke3, S Rafaelsen4.   

Abstract

Purpose: The purpose of this study was to examine the diagnostic accuracy of CEUS in the diagnosis of focal liver lesions, which were undetermined at CT scan. Materials and
Methods: From January 2010 to December 2010, patients with CT-undetermined focal liver lesions were included in this study. A total of 78 patients were evaluated: 41 men and 37 women, mean age 61.8 years; age range 30-91 years. All patients were examined with GE LOGIQ 9E ultrasound scanners with contrast-specific software, and SonoVue intravenous bolus. The standard of reference was composite consisting of: percutaneous biopsy, surgical resection, PET/CT and clinical follow-up.
Results: The 78 included patients had 163 undetermined focal liver lesions, mean size 1.1 cm, range 0.1-5.3 cm. There were 18 malignant and 145 benign liver lesions, as defined by the standard of reference. In differentiating between benign vs. malignant CEUS demonstrated sensitivity, specificity, PPV, NPV and accuracy of 94.4% (95% CI: 56.3-99.5%), 99.3% (95% CI: 94.9 -99.9%), 94.4% (95% CI: 56.3-99.5%), 99.3% (95% CI: 94.9-99.9%) and 98.7% (95% CI: 94.9-99.7%), respectively. If the CEUS-inconclusive results were assumed to indicate malignancy, then sensitivity, specificity, PPV, NPV and accuracy would be 95.8% (95% CI: 66.4-99.6%), 98.6% (95% CI: 94.4-99.7%), 92.0% (95CI: 65.1-98.6%), 99.3% (95% CI: 95.0-99.9%), 98.2% (95% CI: 94.4-99.5%).
Conclusion: The results of this study showed a high diagnostic accuracy for CEUS in undetermined focal liver lesions found by CT. Due to a high diagnostic accuracy of CEUS in this study, it was cautiously concluded that CEUS is useful in differentiating between malignant and benign focal liver lesions in clinical practice.

Entities:  

Keywords:  CEUS; CT; sensitivity; specificity; ultrasound

Year:  2016        PMID: 28286878      PMCID: PMC5340278          DOI: 10.1055/s-0042-120272

Source DB:  PubMed          Journal:  Ultrasound Int Open        ISSN: 2199-7152


  22 in total

1.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

2.  Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.

Authors:  Emilio Quaia; Luca De Paoli; Roberta Angileri; Biagio Cabibbo; Maria Assunta Cova
Journal:  Eur J Radiol       Date:  2013-12-16       Impact factor: 3.528

3.  Diagnostic accuracy studies: how to report and analyse inconclusive test results.

Authors:  Bethany Shinkins; Matthew Thompson; Susan Mallett; Rafael Perera
Journal:  BMJ       Date:  2013-05-16

4.  Characterisation of focal liver lesions with unenhanced and contrast enhanced low MI real time ultrasound: on-site unblinded versus off-site blinded reading.

Authors:  Joachim Hohmann; Jan Skrok; Raffaella Basilico; Manfred Jennett; Anja Müller; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  Eur J Radiol       Date:  2011-11-17       Impact factor: 3.528

5.  Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT.

Authors:  M Völk; M Strotzer; M Lenhart; J Techert; J Seitz; S Feuerbach
Journal:  Acta Radiol       Date:  2001-03       Impact factor: 1.990

6.  Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.

Authors:  F Laghi; O Catalano; M Maresca; F Sandomenico; A Siani
Journal:  Ultraschall Med       Date:  2010-06-01       Impact factor: 6.548

7.  Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.

Authors:  Emilio Quaia
Journal:  Abdom Imaging       Date:  2012-08

8.  Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions.

Authors:  C Beaton; D Cochlin; N Kumar
Journal:  Eur J Surg Oncol       Date:  2009-08-25       Impact factor: 4.424

9.  Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.

Authors:  Alexandra von Herbay; Julia Westendorff; Michael Gregor
Journal:  J Clin Ultrasound       Date:  2010-01       Impact factor: 0.910

Review 10.  Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts.

Authors:  J M Correas; L Bridal; A Lesavre; A Méjean; M Claudon; O Hélénon
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

View more
  2 in total

1.  Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound.

Authors:  Xiao-Feng Wu; Xiu-Mei Bai; Wei Yang; Yu Sun; Hong Wang; Wei Wu; Min-Hua Chen; Kun Yan
Journal:  World J Gastroenterol       Date:  2020-03-07       Impact factor: 5.742

2.  Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions.

Authors:  Maria Cristina Chammas; André Leopoldino Bordini
Journal:  Ultrasonography       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.